Incyte to Present at Upcoming Investor Conferences

Audio By Carbonatix

WILMINGTON, Del.--(BUSINESS WIRE)--Feb 18, 2025--

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of March:

• Cowen 45 th Annual Health Care Conference on Monday, March 3, 2025 at 11:10 am (EST)
• Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11, 2025 at 9:20 am (EST)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250218724163/en/

CONTACT: Incyte ContactsMedia

[email protected]

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA DELAWARE

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH SCIENCE PHARMACEUTICAL RESEARCH

SOURCE: Incyte

Copyright Business Wire 2025.

PUB: 02/18/2025 08:00 AM/DISC: 02/18/2025 08:00 AM

http://www.businesswire.com/news/home/20250218724163/en